Filing Details

Accession Number:
0001415889-24-021480
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-16 17:09:26
Reporting Period:
2024-08-14
Accepted Time:
2024-08-16 17:09:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1810182 Alx Oncology Holdings Inc ALXO Pharmaceutical Preparations (2834) 850642577
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1817127 Sophia Randolph C/O Alx Oncology Holdings Inc.
323 Allerton Avenue
South San Francisco CA 94080
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-08-14 1,365 $2.58 325,711 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.